Skip to main content
. 2023 Mar 1;114(5):2098–2108. doi: 10.1111/cas.15746

FIGURE 2.

FIGURE 2

Landscape of mutations and mutational spectrum of the cohort of AML patients. (A) Gene mutation profile in newly diagnosed unfit AML. (B) Gene mutation profile in relapsed or refractory AML (R/R‐AML). (C) Differences in the prevalence of gene mutations. Comparison of mutation analysis using FoundationOne Heme between the 177 patient Japanese cohort and the 2247 patients in the cohort from the United States and Europe. The symbol size represents the number of cases. SNV, single nucleotide variation